• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道移植中急性排斥反应的挑战。

The challenge of acute rejection in intestinal transplantation.

作者信息

Yoshitoshi E Y, Yoshizawa A, Ogawa E, Kaneshiro M, Takada N, Okamoto S, Fujimoto Y, Sakamoto S, Masuda S, Matsuura M, Nakase H, Chiba T, Tsuruyama T, Haga H, Uemoto S

机构信息

Department of Hepatobiliary, Pancreas, Transplantation and Pediatric Surgery, Kyoto University Hospital, Graduate School of Medicine, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto city, 606-8507, Japan.

出版信息

Pediatr Surg Int. 2012 Aug;28(8):855-9. doi: 10.1007/s00383-012-3110-x. Epub 2012 Jul 4.

DOI:10.1007/s00383-012-3110-x
PMID:22760434
Abstract

Early diagnosis and treatment of acute cellular rejection (ACR) after intestinal transplantation (ITx) is challenging. We report the outcome of three patients: two presented mild ACR improved with steroids. One presented steroid-resistant severe rejection, improved after rabbit anti-thymocyte globulin (r-ATG), but unfortunately died for encephalitis caused by opportunistic infections.

摘要

肠道移植(ITx)后急性细胞排斥反应(ACR)的早期诊断和治疗具有挑战性。我们报告了三名患者的治疗结果:两名患者出现轻度ACR,使用类固醇后病情改善。一名患者出现对类固醇耐药的严重排斥反应,使用兔抗胸腺细胞球蛋白(r-ATG)后病情改善,但不幸的是因机会性感染引起的脑炎死亡。

相似文献

1
The challenge of acute rejection in intestinal transplantation.肠道移植中急性排斥反应的挑战。
Pediatr Surg Int. 2012 Aug;28(8):855-9. doi: 10.1007/s00383-012-3110-x. Epub 2012 Jul 4.
2
Ten-Year Experience With Bowel Transplantation at Seoul St. Mary's Hospital.首尔圣母医院肠道移植十年经验
Transplant Proc. 2016 Mar;48(2):473-8. doi: 10.1016/j.transproceed.2015.12.065.
3
Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.肾移植中新型免疫抑制方案的临床疗效与成本效益:一项系统评价与模型研究
Health Technol Assess. 2005 May;9(21):1-179, iii-iv. doi: 10.3310/hta9210.
4
Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.肾移植中早期撤用类固醇诱导抗体治疗:比较抗 IL-2 受体和抗胸腺细胞球蛋白的长期结果。
Int Immunopharmacol. 2011 Nov;11(11):1832-6. doi: 10.1016/j.intimp.2011.07.012. Epub 2011 Aug 9.
5
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period.达利珠单抗和阿仑单抗作为成人肠道和多脏器移植的诱导剂:40例受者术后早期的排斥反应和感染率
Transplant Proc. 2010 Jan-Feb;42(1):35-8. doi: 10.1016/j.transproceed.2009.12.019.
6
Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection.兔抗胸腺细胞球蛋白(即胸腺球蛋白):其在预防和治疗急性肾移植排斥反应中的应用综述
Drugs. 2009 Jul 30;69(11):1483-512. doi: 10.2165/00003495-200969110-00007.
7
Evolutionary experience with immunosuppression in pediatric intestinal transplantation.小儿肠道移植免疫抑制的进化经验。
J Pediatr Surg. 2005 Jan;40(1):274-9; discussion 279-80. doi: 10.1016/j.jpedsurg.2004.09.020.
8
Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.在接受以他克莫司为基础的免疫抑制方案的致敏肾移植受者中,单次大剂量抗胸腺细胞球蛋白与巴利昔单抗作为诱导治疗的比较。
Transpl Immunol. 2008 Jan;18(3):281-5. doi: 10.1016/j.trim.2007.08.002. Epub 2007 Aug 28.
9
Steroid maintenance in repeat kidney transplantation: influence of induction agents on outcomes.重复肾移植中的类固醇维持治疗:诱导剂对结局的影响。
Saudi J Kidney Dis Transpl. 2014 Jul;25(4):741-9. doi: 10.4103/1319-2442.134954.
10
Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab.肺移植中的诱导治疗:一项比较OKT3、抗胸腺细胞球蛋白和达利珠单抗的前瞻性对照临床试验。
J Heart Lung Transplant. 2001 Dec;20(12):1282-90. doi: 10.1016/s1053-2498(01)00356-4.

本文引用的文献

1
Current status of intestinal transplantation in Japan.日本肠道移植的现状。
Transplant Proc. 2011 Jul-Aug;43(6):2405-7. doi: 10.1016/j.transproceed.2011.05.043.
2
Intestinal transplantation.肠道移植
N Engl J Med. 2009 Sep 3;361(10):998-1008. doi: 10.1056/NEJMra0804605.
3
Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance.肠道和多脏器移植受者免疫抑制策略的演变,特别涉及同种异体移植免疫和部分耐受的实现。
Transpl Int. 2009 Jan;22(1):96-109. doi: 10.1111/j.1432-2277.2008.00785.x. Epub 2008 Oct 24.
4
Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: a possible evidence of acute humoral sensitization.HLA抗体出现与肠道移植受者急性排斥反应的关联:急性体液致敏的可能证据。
Transplant Proc. 2006 Jul-Aug;38(6):1735-7. doi: 10.1016/j.transproceed.2006.05.058.
5
Histopathologic characteristics of human intestine allograft acute rejection in patients pretreated with thymoglobulin or alemtuzumab.
Am J Gastroenterol. 2006 Jul;101(7):1617-24. doi: 10.1111/j.1572-0241.2006.00611.x.
6
Liver and intestine transplantation: summary analysis, 1994-2003.肝脏与肠道移植:1994 - 2003年总结分析
Am J Transplant. 2005 Apr;5(4 Pt 2):916-33. doi: 10.1111/j.1600-6135.2005.00839.x.